Enliven Therapeutics, Inc. (ELVN) — Analyst estimates
Consensus analyst estimates for Enliven Therapeutics, Inc. — earnings, revenue, and price targets.
| Fiscal Year | Revenue Forecast | EPS Forecast | analysts |
|---|---|---|---|
| 2026 | 0 | -0.54 | 1 |
| 2027 | 0 | -0.73 | 1 |
| 2028 | 16.67K | -2.98 | 7 |
| 2029 | 73.05M | -2.79 | 2 |
| 2030 | 339.83M | -1.29 | 5 |
Consensus analyst estimates by fiscal year.